Caseware UK (AP4) 2024.0.164 2024.0.164 2024-09-302024-09-302023-10-012false2No description of principal activityfalsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 14069299 2023-10-01 2024-09-30 14069299 2022-04-26 2023-09-30 14069299 2024-09-30 14069299 2023-09-30 14069299 c:Director1 2023-10-01 2024-09-30 14069299 c:Director2 2023-10-01 2024-09-30 14069299 c:RegisteredOffice 2023-10-01 2024-09-30 14069299 d:CurrentFinancialInstruments 2024-09-30 14069299 d:CurrentFinancialInstruments 2023-09-30 14069299 d:CurrentFinancialInstruments d:WithinOneYear 2024-09-30 14069299 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 14069299 d:ShareCapital 2024-09-30 14069299 d:ShareCapital 2023-09-30 14069299 d:RetainedEarningsAccumulatedLosses 2024-09-30 14069299 d:RetainedEarningsAccumulatedLosses 2023-09-30 14069299 c:OrdinaryShareClass1 2023-10-01 2024-09-30 14069299 c:OrdinaryShareClass1 2024-09-30 14069299 c:OrdinaryShareClass2 2023-10-01 2024-09-30 14069299 c:OrdinaryShareClass2 2024-09-30 14069299 c:OrdinaryShareClass3 2023-10-01 2024-09-30 14069299 c:OrdinaryShareClass3 2024-09-30 14069299 c:OrdinaryShareClass4 2023-10-01 2024-09-30 14069299 c:OrdinaryShareClass4 2024-09-30 14069299 c:OrdinaryShareClass5 2023-10-01 2024-09-30 14069299 c:OrdinaryShareClass5 2024-09-30 14069299 c:FRS102 2023-10-01 2024-09-30 14069299 c:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 14069299 c:FullAccounts 2023-10-01 2024-09-30 14069299 c:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 14069299 d:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-10-01 2024-09-30 14069299 d:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-09-30 14069299 d:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-09-30 14069299 e:PoundSterling 2023-10-01 2024-09-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 14069299









MENNAYE MEDICAL LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2024

 
MENNAYE MEDICAL LTD
 
 
COMPANY INFORMATION


Directors
D E Maskell 
J C Maskell 




Registered number
14069299



Registered office
7 The Close

Norwich

Norfolk

NR1 4DJ




Accountants
MA Partners LLP
Chartererd Accountants

7 The Close

Norwich

Norfolk

NR1 4DJ





 
MENNAYE MEDICAL LTD
 

CONTENTS



Page
Accountants' report
 
 
1
Balance sheet
 
 
2 - 3
Notes to the financial statements
 
 
4 - 6


 
MENNAYE MEDICAL LTD
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF MENNAYE MEDICAL LTD
FOR THE YEAR ENDED 30 SEPTEMBER 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Mennaye Medical Ltd for the year ended 30 September 2024 which comprise  the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the Board of directors of Mennaye Medical Ltd, as a body, in accordance with the terms of our engagement letter dated 10 May 2022Our work has been undertaken solely to prepare for your approval the financial statements of Mennaye Medical Ltd and state those matters that we have agreed to state to the Board of directors of Mennaye Medical Ltd, as a body, in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Mennaye Medical Ltd and its Board of directors, as a body, for our work or for this report. 

It is your duty to ensure that Mennaye Medical Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Mennaye Medical Ltd. You consider that Mennaye Medical Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Mennaye Medical Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  





MA Partners LLP
 
Chartererd Accountants
  
7 The Close
Norwich
Norfolk
NR1 4DJ

5 March 2025
Page 1

 
MENNAYE MEDICAL LTD
REGISTERED NUMBER: 14069299

BALANCE SHEET
AS AT 30 SEPTEMBER 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
2,324
-

Cash at bank and in hand
  
40,466
8,496

  
42,790
8,496

Creditors: amounts falling due within one year
 5 
(12,905)
(5,610)

Net current assets
  
 
 
29,885
 
 
2,886

  

Net assets
  
29,885
2,886


Capital and reserves
  

Called up share capital 
 6 
100
100

Profit and loss account
  
29,785
2,786

  
29,885
2,886


Page 2

 
MENNAYE MEDICAL LTD
REGISTERED NUMBER: 14069299
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 5 March 2025.






D E Maskell
Director

The notes on pages 4 to 6 form part of these financial statements.

Page 3

 
MENNAYE MEDICAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1.


General information

Mennaye Medical Ltd is a private company limited by shares, incorporated and domiciled in England and Wales. The address of its registered office is 7 The Close, Norwich, Norfolk, NR1 4DJ
The Company's principal place of business is Norwich and the Company's principal activity is that of the provision of specialist medical practice activities.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is measured at the fair value of the consideration received or receivable.  Revenue for specialist medical services is recognised in the period in which the services are provided.

 
2.3

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.4

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.6

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Page 4

 
MENNAYE MEDICAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.7

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including the directors, during the year was 2 (2023 - 2).






4.


Debtors

2024
2023
£
£


Other debtors
2,324
-

2,324
-



5.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
10,293
3,125

Other creditors
-
852

Accruals and deferred income
2,612
1,633

12,905
5,610


Page 5

 
MENNAYE MEDICAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

6.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



35 A Ordinary shares shares of £1.00 each
35
35
35 B Ordinary shares shares of £1.00 each
35
35
10 C Ordinary shares shares of £1.00 each
10
10
10 D Ordinary shares shares of £1.00 each
10
10
10 E Ordinary shares shares of £1.00 each
10
10

100

100



7.


Transactions with directors

As at 1 October 2023, the Company owed the directors £852.  As at 30 September 2024, the directors owed the Company £2,324.  The loan is interest free and included within other debtors in note 4 to the financial statements. 

 
Page 6